To illustrate how the two-pronged modeling approach described above can also identify or corroborate novel therapeutic targets for ALS, and to show the level of information provided, we chose MATR3 (Matrin-3) as an example. The gene discussed is MATR3; the disease is amyotrophic lateral sclerosis.